Clinical Trial Update: A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 randomized, double-blind study of chloroquine in breast cancer (invasive) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Breast Cancer

Drugs mentioned

• Aralen (chloroquine)
• Chloroquine (chloroquine)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer, Invasive Breast Cancer | Phase 2 | Status: UNKNOWN